BioNTech SE - American Depositary Shares (NQ:BNTX)

96.90 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

73 74 Next >

More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone ↗

September 15, 2023

New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...

Via Benzinga

The 3 Most Undervalued Pharma Stocks to Buy in September 2023 ↗

September 14, 2023

Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.

Via InvestorPlace

Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗

September 13, 2023

Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.

Via Investor's Business Daily

DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories ↗

September 12, 2023

Benzinga

Via Benzinga

BioNTech Unusual Options Activity For August 30 ↗

August 30, 2023

Via Benzinga

Expert Ratings for BioNTech ↗

August 28, 2023

Via Benzinga

BioNTech Unusual Options Activity For August 21 ↗

August 21, 2023

Via Benzinga

Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits ↗

September 11, 2023

The U.S.

Via Benzinga

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

September 11, 2023

From Pfizer Inc.

Via Business Wire

Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry ↗

September 06, 2023

On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...

Via Benzinga

Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant ↗

September 06, 2023

Pirola has about 30 mutations compared with previous omicron versions of the virus.

Via Investor's Business Daily

3 Stocks to Buy For the COVID Resurgence

September 06, 2023

The cold and flu season is upon us, but COVID-19 cases and hospitalizations have also increased recently. The Centers for Disease Control (CDC) will be voting

Via MarketBeat

Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle ↗

September 05, 2023

Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...

Via Benzinga

Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal ↗

September 02, 2023

Shanghai GenFleet Technologies partnered three preclinical small-molecule candidates for RAS pathway-driven cancers to Verastem Oncology in a deal that could be worth up to $625.5 million. GenFleet...

Via Talk Markets

Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43%: Today's Top Stories ↗

September 01, 2023

Tech Crunch

Via Benzinga

Topics Lawsuit

Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns ↗

September 01, 2023

The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE (NASDAQ:

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

August 30, 2023

From Pfizer Inc.

Via Business Wire

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

August 30, 2023

From BioNTech SE

Via GlobeNewswire

Why Novavax Stock Was So Healthy on Monday ↗

August 28, 2023

As the coronavirus threat rises, so too does the vaccine maker's value to investors.

Via The Motley Fool

Why BioNTech Shares Are Rising During Monday's Session ↗

August 28, 2023

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S.

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

August 28, 2023

Via Benzinga

COVID Is Making a Comeback: Should You Buy These 2 Stocks? ↗

August 27, 2023

Can these companies keep up their recent momentum?

Via The Motley Fool

Novavax (NVAX) Stock Is Getting Ready to Rally Again ↗

August 22, 2023

Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.

Via InvestorPlace

Why Moderna, BioNTech SE, and Novavax Surged Today ↗

August 21, 2023

The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.

Via The Motley Fool

Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 21, 2023

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.

Via Benzinga

Moderna, BioNTech And Other Big Stocks Moving Higher On Monday ↗

August 21, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58....

Via Benzinga

Topics Stocks

Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance ↗

August 18, 2023

The companies are hoping to launch their updated Covid shots in September.

Via Investor's Business Daily

Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies ↗

August 18, 2023

Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies...

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗

August 17, 2023

This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.

Via InvestorPlace

BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer

August 14, 2023

From BioNTech SE

Via GlobeNewswire

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.